Oral Administration of <i>Lactobacillus sakei</i> CVL-001 Improves Recovery from Dextran Sulfate Sodium-Induced Colitis in Mice by Microbiota Modulation

Oral Administration of <i>Lactobacillus sakei</i> CVL-001 Improves Recovery from Dextran Sulfate Sodium-Induced Colitis in Mice by Microbiota Modulation

Inflammatory bowel disease (IBD) is an intestinal chronic inflammatory disease, and its incidence is steadily increasing. IBD is closely related to the intestinal microbiota, and probiotics are known to be a potential therapeutic agent for IBD. In our study, we evaluated the protective effect of <...

Full description

Bibliographic Details
Main Authors: Dong-Yeon Kim, Tae-Sung Lee, Do-Hyeon Jung, Eun-Jung Song, Ah-Ra Jang, Ji-Yeon Park, Jae-Hun Ahn, In-Su Seo, Seung-Ju Song, Yeong-Jun Kim, Yun-Ji Lee, Yeon-Ji Lee, Jong-Hwan Park
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Microorganisms
Subjects:
inflammatory bowel disease
<i>Lactobacillus sakei</i> CVL-001
anti-inflammation
epithelial barrier
microbiota
Online Access:https://www.mdpi.com/2076-2607/11/5/1359

Internet

https://www.mdpi.com/2076-2607/11/5/1359

Similar Items